The New Rules of Retina Drug Development - Quiz - MDSpire

The New Rules of Retina Drug Development

In a panel at the Retina Innovation Summit in Montreal, regulatory experts, drug developers, academic advisors, and investors discussed how evolving FDA guidance is reshaping the path from clinical trials to approval.

  • By

  • Jim Gallagher, senior managing editor

  • July 15, 2026

  • 5 min

Share

Original Source(s)

The New Rules of Retina Drug Development

  • by Jim Gallagher, senior managing editor

  • July 15, 2026

Related Content

Longitudinal assessment of intraocular pressure in the 5xFAD mouse model of Alzheimer's disease

Ocular Toxoplasmosis Review

Sleep, stress, and pregnancy emerge as potential drivers of ocular toxoplasmosis recurrence in recent retrospective study

  • July 15, 2026

  • 4 min
Successful outcomes of pediatric dacryocystorhinostomy with adjunctive 5-fluorouracil